A transthoracic echocardiogram is a procedure in which a technician obtains views of the heart by moving a small instrument to different locations on the chest or abdominal wall. The instrument sends sound waves into the chest and can identify potential cardiac problems based on echoes received. The Adult Transthoracic Echocardiography accreditation recognizes that G-CMC meets or exceeds high-quality echocardiography procedural standards set by the IAC.
“Accreditation by the IAC demonstrates that we at G-CMC are delivering high-quality care when testing heart health,” said Stephen Voyce, M.D., chief of cardiology and co-director, the Geisinger Heart and Vascular Institute at G-CMC.
“Together with our other cardiovascular services, we’re helping to effectively prevent and treat heart disease,” added Madhava Rao, M.D., director of noninvasive cardiology, the Geisinger Heart and Vascular Institute at G-CMC.
IAC accreditation is a “seal of approval” that patients can rely on as an indication that the facility has been carefully critiqued on all aspects of its operations considered relevant by medical experts in the field of echocardiography. When scheduling an echocardiogram, patients are encouraged to inquire about the accreditation status of the facility where they will be evaluated.
Cardiovascular disease – any condition of the heart or blood vessels – is the primary cause of death in the United States. On average, one American dies every 39 seconds of cardiovascular disease. The American Heart Association estimates that the direct and indirect cost for cardiovascular disease in the U.S. for 2010 was $503.2 billion. Early detection of life-threatening heart disorders and other diseases is possible through the use of echocardiography procedures performed within IAC-accredited hospitals, such as G-CMC.
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.